Three-year Outcome of iRoot BP Plus Pulpotomy in Primary Molars: A Retrospective Study

doi:10.13701/j.cnki.kqyxyj.2022.07.018

Abstract

Abstract: Objective: To observe the three-year curative effect of iroot BP plus pulpotomy of primary molars and analyze the influencing factors. Methods: In the electronic medical record database of Shenzhen Children's Hospital, the treatment records of iroot BP plus pulpotomy for deep caries of primary molars in the Department of Stomatology from January to December 2018 were retrieved. The patients aged 7 years and below, with a follow-up period of not less than 3 years and complete medical records were collected, and the primary molars following pulpotomy with iroot BP plus for deep caries of the patients were selected as the research objects. According to AAPD clinical and imaging evaluation criteria, the treatment success rate was calculated and the influencing factors were analyzed. Results: Fifty-eight teeth were finally included. The 3-year success rate was 87.93% (51/58). There was no significant difference in the success rate among different gender, ages, tooth position, dentition, hemostasis time, and crown restoration method (P>0.05). Conclusion: iroot BP plus has good therapeutic effect in the 3-year follow-up period of pulpotomy of primary molars.

Key words: deciduous molars, pulpotomy, bioceramics

ZHONG Wanjin, LI Yuemei, CHEN Chanchan, CHANG Huihui, DING Guicong. Three-year Outcome of iRoot BP Plus Pulpotomy in Primary Molars: A Retrospective Study[J]. Journal of Oral Science Research, 2022, 38(7): 669-672.

References

[1] 冯希平.中国居民口腔健康状况——第四次中国口腔健康流行病学调查报告[C]//2018年中华口腔医学会第十八次口腔预防医学学术年会论文汇编,2018.
[2] Dogan S, Duruturk L, Orhan AI,et al. Determining treatibility of primary teeth with pulpal exposure [J]. J Clin Pediatr Dent, 2013, 37(4): 345-350.
[3] Pulp therapy for primary and immature permanent teeth [J]. Pediatr Dent, 2018, 40(6): 343-351.
[4] 郑佳佳,张笋,葛立宏.我国乳牙牙髓切断术临床应用现况调查[J].现代口腔医学杂志,2014,28(5):296-299.
[5] Carti O, Oznurhan F. Evaluation and comparison of mineral trioxide aggregate and biodentine in primary tooth pulpotomy: Clinical and radiographic study [J]. Niger J Clin Pract, 2017, 20(12): 1604-1609.
[6] El Meligy O, Alamoudi NM, Allazzam SM,et al. Biodentine^TM versus formocresol pulpotomy technique in primary molars: a 12-month randomized controlled clinical trial [J]. BMC Oral Health, 2019, 19(1): 3.
[7] Celik BN, Mutluay MS, Arikan V,et al. The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth [J]. Clin Oral Investig, 2019, 23(2): 661-666.
[8] Asgary S, Shirvani A, Fazlyab M. MTA and ferric sulfate in pulpotomy outcomes of primary molars: a systematic review and meta-analysis [J]. J Clin Pediatr Dent, 2014, 39(1): 1-8.
[9] Shirvani A, Asgary S. Mineral trioxide aggregate versus formocresol pulpotomy: a systematic review and meta-analysis of randomized clinical trials [J]. Clin Oral Investig, 2014, 18(4): 1023-1030.
[10] Godhi B, Tyagi R. Success rate of MTA pulpotomy on vital pulp of primary molars: A 3-year observational study [J]. Int J Clin Pediatr Dent, 2016, 9(3): 222-227.
[11] Elkhadem A, Nagi P. Effectiveness of MTA pulpotomy in primary molars: a critical assessment of relevant studies [J]. Evid Based Dent, 2013, 14(2): 46.
[12] 麦丽嘉,袁国华.乳牙盖髓剂MTA与新型生物材料Biodentine的比较[J].口腔医学研究,2021,37(1): 19-22.
[13] 董艳梅.活髓保存治疗与生物活性盖髓剂的临床现状与研究[J].中华口腔医学杂志,2014,49(05): 268-271.
[14] 刘思毅,宫玮玉,刘木清,等.成熟恒牙因龋露髓行生物陶瓷材料直接盖髓术的临床疗效观察[J].中华口腔医学杂志,2020,55(12):945-951.
[15] 王爽,刘鹤,赵双云,等.两种生物陶瓷材料用于乳磨牙牙髓切断术的随机对照研究[J].中华口腔医学杂志,2021,56(2):145-151.
[16] Dhar V, Marghalani AA, Crystal YO, et al. Use of vital pulp therapies in primary teeth with deep caries lesions [J]. Pediatr Dent, 2017, 39(5):146-159.
[17] Hutcheson C, Seale NS, Mcwhorter A, et al. Multi-surface composite vs stainless steel crown restorations after mineral trioxide aggregate pulpotomy: a randomized controlled trial [J]. Pediatr Dent, 2012, 34(7): 460-467.
[18] 窦桂丽,吴南,赵双云,等.乳磨牙牙髓切断术两年疗效观察及其影响因素回顾性分析[J].北京大学学报(医学版), 2018, 50(1): 170-175.
[19] Nasrallah H, El Noueiri B, Pilipili C, et al. Clinical and radiographic evaluations of biodentine pulpotomies in mature primary molars (stage 2) [J]. Int J Clin Pediatr Dent, 2018, 11(6): 496-504.
[20] Maroto M, Barbería E, Vera V, et al. Mineral trioxide aggregate as pulp dressing agent in pulpotomy treatment of primary molars: 42-month clinical study [J]. Am J Dent, 2007, 20(5): 283-286.
[21] Cardoso-Silva C, Barbería E, Maroto M, et al. Clinical study of mineral trioxide aggregate in primary molars. Comparison between grey and white MTA-a long term follow-up (84 months) [J]. J Dent, 2011, 39(2): 187-193.